additional osp comments: ta on risky research review act

5 messages over —, 2024-07-15 – 2024-07-15.

1. 2024-07-15 12:26 Sara Selgrade open PDF p.114
   Hello all, For your awareness, we are providing the attached comments on the Risky Research Review Act from the NIH Office of Science Policy (OSP). We anticipate receiving consolidated NIH comments on the bill, and we will share these as soon as we have them. Please let me know if you have any questions. Thanks, Sara
2. 2024-07-15 12:26 Sara Selgrade open PDF p.123
   ol ol a 5 AM [AID DEA DART NIAID) [E] 7 NIAID) [E] \IH/NIAID) [E] ii NIH/NIAID) [E] J VIH/NIAID) [I] iy >; I I (NIH/NIAID) [E] NIH/NIAID) [E] ay NIAID) [E] In the attached revised draft, I jections, I will submit these to NIH tt iy PM [AID DEA DART NIAID) (E] i I NIAID) [E] \IH/NIAID) [E] ii NIH/NIAID) [E] J VIH/NIAID) [Ee] >; I I (NIH/NIAID) [E] NIH/NIAID) [E] ay NIAID) [E] Hello all, For your awareness, we are providing the attached comments on the Risky Research Review Act from the NIH Office of Science Policy (OSP). We anticipate receiving consolidated NIH comments on the bill, and we will share these as soon as we have them. Please let me know if you have any questions. Thanks, Sara
3. 2024-07-15 12:26 Sara Selgrade open PDF p.133
   Hello all, For your awareness, we are providing the attached comments on the Risky Research Review Act from the NIH Office of Science Policy (OSP). We anticipate receiving consolidated NIH comments on the bill, and we will share these as soon as we have them. ol ol a 5 AM AID DEA DART NIAID) [E] 7 NIAID) [E] \IH/NIAID) [E] ii a NIH/NIAID) [E] VIH/NIAID) [E] iy >; || (NIH/NIAID) [E] NIH/NIAID) [E] ay NIAID) [E] In the attached revised draft, I jections, I will submit these to NIH D) (e)] PM [AID DEA DART NIAID) (E] i I \IH/NIAID) [E] ii a NIH/NIAID) [E] NIAID) [E] VIH/NIAID) [E] iy >; I I (NIH/NIAID) [E] NIH/NIAID) [E] ay NIAID) [E] has asked us to Please let me know if you have any questions. Thanks, Sara
4. 2024-07-15 12:26 Sara Selgrade open PDF p.143
   Hello all, For your awareness, we are providing the attached comments on the Risky Research Review Act from the NIH Office of Science Policy (OSP). We anticipate receiving consolidated NIH comments on the bill, and we will share these as soon as we have them. Please let me know if you have any questions. Thanks, ol ol a 5 AM AID DEA DART NIAID) [E] 7 NIAID) [E] \IH/NIAID) [E] ii NIH/NIAID) [E] J VIH/NIAID) [I] iy >; I I (NIH/NIAID) [E] NIH/NIAID) [E] ay NIAID) [E] In the attached revised draft, I jections, I will submit these to NIH tt iy PM [AID DEA DART NIAID) (E] i I NIAID) [E] \IH/NIAID) [E] ii NIH/NIAID) [E] J VIH/NIAID) [Ee] >; I I (NIH/NIAID) [E] NIH/NIAID) [E] ay NIAID) [E] has asked us to ze Sara
5. 2024-07-15 12:26 Sara Selgrade open PDF p.154
   Hello all, For your awareness, we are providing the attached comments on the Risky Research Review Act from the NIH Office of Science Policy (OSP). We anticipate receiving consolidated NIH comments on the bill, and we will share these as soon as we have them. Please let me know if you have any questions. Thanks, Sara